Discover
TRML
Tourmaline Bio, Inc.
47.98
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | 136.59% | |
| 1y | 80.44% |
47.98
day range
47.98
11.56
52 week range
48.27
| Open | 47.98 | Prev Close | 47.98 | Low | 47.98 | High | 47.98 | Mkt Cap | 1.23B |
| Vol | 779.87K | Avg Vol | 1.01M | EPS | -3.44 | P/E | N/A | Forward P/E | -13.18 |
| Beta | 1.58 | Short Ratio | 1.12 | Inst. Own | 89.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 42.23 | 200-d Avg | 23.14 | 1yr Est | 48.00 |
| Income Statement | |||
| Operating Expenses | 25.97M | ||
| Research and Development Expense | 19.63M | ||
| Selling, General and Administrative Expense | 6.34M | ||
| Operating Income | -25.97M | ||
| Net Income | -23.09M | ||
| Net Income Common Stock | -23.09M | ||
| Net Income Common Stock (USD) | -23.09M | ||
| Consolidated Income | -23.09M | ||
| Earnings per Basic Share | -0.90 | ||
| Earnings per Basic Share (USD) | -0.90 | ||
| Earnings per Diluted Share | -0.90 | ||
| Earning Before Interest & Taxes (EBIT) | -23.09M | ||
| Earning Before Interest & Taxes (USD) | -23.09M | ||
| Weighted Average Shares | 25.76M | ||
| Weighted Average Shares Diluted | 25.76M | ||
| Balance Sheet | |||
| Cash and Equivalents | 31.65M | ||
| Cash and Equivalents (USD) | 31.65M | ||
| Investments | 225.00M | ||
| Investments Current | 207.81M | ||
| Investments Non-Current | 17.18M | ||
| Current Assets | 249.10M | ||
| Property, Plant & Equipment Net | 174.00K | ||
| Total Assets | 269.30M | ||
| Debt Current | 145.00K | ||
| Total Debt | 145.00K | ||
| Current Liabilities | 10.10M | ||
| Total Liabilities | 10.10M | ||
| Accumulated Retained Earnings (Deficit) | -181.32M | ||
| Accumulated Other Comprehensive Income | 121.00K | ||
| Shareholders Equity | 259.19M | ||
| Shareholders Equity (USD) | 259.19M | ||
| Assets Non-Current | 20.19M | ||
| Total Debt (USD) | 145.00K | ||
| Liabilities Non-Current | 8.00K | ||
| Trade and Non-Trade Payables | 3.17M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 56.00K | ||
| Net Cash Flow from Financing | 54.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.91M | ||
| Capital Expenditure | -7.00K | ||
| Issuance (Purchase) of Equity Shares | 54.00K | ||
| Net Cash Flow from Investing | 16.30M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 16.31M | ||
| Net Cash Flow from Operations | -20.26M | ||
| Share Based Compensation | 2.47M | ||